A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone

NCT03433001 · clinicaltrials.gov ↗

COMPLETED

Status

295

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

DRUG: Ixazomib
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Takeda